SLC7A11 and hepatocellular carcinoma: Various other factors, including the transcription factors YAP/TAZ, lncRNA DUXAP8, fatty acid synthase (FASN), and ABCC5, may also inhibit sorafenib-induced ferroptosis by elevating SLC7A11 expression and reducing HCC sensitivity to ferroptosis [62–65].